The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu(University of North Carolina at Chapel Hill), Charles M. Perou(University of North Carolina at Chapel Hill), Edward William Nelson(University of Utah), Philip S. Bernard(University of Utah), Juan Palazzo(Thomas Jefferson University), Andrew B. Nobel(University of North Carolina at Chapel Hill), Lynda Sawyer(University of North Carolina at Chapel Hill), Alejandra Ruiz Orrico(Thomas Jefferson University), Donna Dreher(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Joel S. Parker(University of North Carolina at Chapel Hill), Xiaping He(University of North Carolina at Chapel Hill), Chad Livasy(University of North Carolina at Chapel Hill), Matthew J. Ellis(Guardant (United States)), Olufunmilayo I. Olopade(University of Chicago), J. S. Marron(University of North Carolina at Chapel Hill), Mary C. Mone(University of Utah), Yudong Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Bahjat F. Qaqish(University of North Carolina at Chapel Hill), Daniel Oh(University of Southern California), Laurent Perreard(ARUP Laboratories (United States)), Michael E. Mullins(University of North Carolina at Chapel Hill), John F. Quackenbush(University of Utah), Cheng Fan(University of North Carolina at Chapel Hill), Matthew G. Ewend, Evangeline Reynolds(University of North Carolina at Chapel Hill), Junyuan Wu(University of North Carolina at Chapel Hill), Lynn G. Dressler(University of North Carolina at Chapel Hill), Rita Nanda(University of Chicago), Heidi J. Hansen(University of Utah), Maria Tretiakova(University of Washington)
Cited by 1,470
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k